Outcomes of direct oral anticoagulants in atrial fibrillation patients across different body mass index categories

AF Barakat, S Jain, A Masri, L Alkukhun… - Clinical …, 2021 - jacc.org
Objectives This study sought to evaluate direct oral anticoagulant (DOAC) outcomes (vs.
warfarin) in patients with atrial fibrillation (AF) across body mass index (BMI) categories …

[引用][C] Outcomes of Direct Oral Anticoagulants in Atrial Fibrillation Patients Across Different Body Mass Index Categories

AF Barakat, S Jain, A Masri, L Alkukhun… - JACC: Clinical …, 2021 - cir.nii.ac.jp
Outcomes of Direct Oral Anticoagulants in Atrial Fibrillation Patients Across Different Body Mass
Index Categories | CiNii Research CiNii 国立情報学研究所 学術情報ナビゲータ[サイニィ] 詳細へ …

Outcomes of Direct Oral Anticoagulants in Atrial Fibrillation Patients Across Different Body Mass Index Categories.

AF Barakat, S Jain, A Masri, L Alkukhun… - JACC. Clinical …, 2021 - europepmc.org
Objectives This study sought to evaluate direct oral anticoagulant (DOAC) outcomes (vs.
warfarin) in patients with atrial fibrillation (AF) across body mass index (BMI) categories …

[HTML][HTML] Outcomes of Direct Oral Anticoagulants in Atrial Fibrillation Patients Across Different Body Mass Index Categories

AF Barakat, S Jain, A Masri, L Alkukhun… - JACC: Clinical …, 2021 - Elsevier
Objectives This study sought to evaluate direct oral anticoagulant (DOAC) outcomes (vs.
warfarin) in patients with atrial fibrillation (AF) across body mass index (BMI) categories …

Outcomes of Direct Oral Anticoagulants in Atrial Fibrillation Patients Across Different Body Mass Index Categories

AF Barakat, S Jain, A Masri… - JACC: Clinical …, 2021 - ohsu.elsevierpure.com
Objectives: This study sought to evaluate direct oral anticoagulant (DOAC) outcomes (vs.
warfarin) in patients with atrial fibrillation (AF) across body mass index (BMI) categories …

Outcomes of Direct Oral Anticoagulants in Atrial Fibrillation Patients Across Different Body Mass Index Categories

AF Barakat, S Jain, A Masri… - JACC. Clinical …, 2021 - pubmed.ncbi.nlm.nih.gov
Objectives This study sought to evaluate direct oral anticoagulant (DOAC) outcomes (vs.
warfarin) in patients with atrial fibrillation (AF) across body mass index (BMI) categories …